DrugPatentWatch Database Preview
Drugs in Development Information for Salvinorin A
What is the drug development status for Salvinorin A?
Salvinorin A is an investigational drug.
There have been 4 clinical trials for Salvinorin A.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 14th 2017.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Johns Hopkins University, National Alliance for Research on Schizophrenia and Depression, and California Pacific Medical Center Research Institute.
There are eighty-eight US patents protecting this investigational drug and three hundred and sixty-eight international patents.
Summary for Salvinorin A
| US Patents | 88 |
| International Patents | 368 |
| US Patent Applications | 190 |
| WIPO Patent Applications | 109 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2017-12-14) |
| Vendors | 17 |
Recent Clinical Trials for Salvinorin A
| Title | Sponsor | Phase |
|---|---|---|
| Effects of Salvinorin A on Brain Function | Johns Hopkins University | Phase 1/Phase 2 |
| Placebo Controlled Study of Sublingual Salvinorin A | California Pacific Medical Center Research Institute | N/A |
| Effects of Salvinorin A in Healthy Controls | National Alliance for Research on Schizophrenia and Depression | Phase 1 |
Clinical Trial Summary for Salvinorin A
Top disease conditions for Salvinorin A
Top clinical trial sponsors for Salvinorin A
US Patents for Salvinorin A
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Salvinorin A | Start Trial | Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof | Start Trial | |
| Salvinorin A | Start Trial | Pharmaceutical composition and method of manufacturing | CURE PHARMACEUTICAL HOLDING CORP. (Oxnard, CA) | Start Trial |
| Salvinorin A | Start Trial | Pharmaceutical compositions resistant to abuse | EGALET LTD. (London, GB) | Start Trial |
| Salvinorin A | Start Trial | Multifunctional aminoquinoline therapeutic agents | LOHOCLA RESEARCH CORPORATION (Evanston, IL) | Start Trial |
| Salvinorin A | Start Trial | Methods, devices and systems for pulmonary delivery of active agents | Syqe Medical Ltd. (Tel-Aviv, IL) | Start Trial |
| Salvinorin A | Start Trial | Kappa opioid ligands | The Scripps Research Institute (La Jolla, CA) | Start Trial |
| Salvinorin A | Start Trial | Agonists of the mu opioid receptor | UNIVERSITY OF KANSAS (Lawrence, KS) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Salvinorin A
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Salvinorin A | European Patent Office | 3324975 | 2035-07-22 | Start Trial |
| Salvinorin A | World Intellectual Property Organization (WIPO) | 2017015309 | 2035-07-22 | Start Trial |
| Salvinorin A | Australia | 2010211376 | 2029-02-06 | Start Trial |
| Salvinorin A | Australia | 2013257533 | 2029-02-06 | Start Trial |
| Salvinorin A | Canada | 2751627 | 2029-02-06 | Start Trial |
| Salvinorin A | Denmark | 2393487 | 2029-02-06 | Start Trial |
| Salvinorin A | European Patent Office | 2393487 | 2029-02-06 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
